期刊文献+

15株临床分离耐药大肠杆菌耐氟喹诺酮类抗生素基因的检测与序列分析 被引量:12

Detection and analysis of the fluoroquinolone resistance gene sequence from 15 clinical isolates of antibiotic-resistant Escherichia coli
原文传递
导出
摘要 15株动物源性耐氟喹诺酮类药物大肠杆菌进行PCR检测、测序、WDNASIS软件分析gyrA基因中的氟喹诺酮耐药决定区(QRDR)、AcrA以及编码与质粒介导的氟喹诺酮类药物耐药机制相关的qnrA、qnrB、qnrS、qepA和aac(6′)-Ib-cr基因。结果表明,15株耐药菌中,QRDR基因在其编码第72、75、83位或第87位氨基酸均发生突变;AcrA基因未检测到氨基酸的突变;qnrS、qepA和aac(6′)-Ib-cr耐药基因阳性菌各检测到1株,序列分析表明不存在氨基酸突变。QRDR基因编码的氨基酸4个位点发生突变,其中Ser83→Leu和Asp87→Asn 2个基因的突变均与文献报道的突变相同,双突变的7个菌株均表现为高度耐氟喹诺酮类抗生素,表明gyrA基因为大肠杆菌耐氟喹诺酮类抗生素的一个重要机制。高度耐氟喹诺酮类抗生素的菌株中有2株没有检测到氨基酸突变的存在,但是aac-(6′)-Ib-cr基因和qnrS检测为阳性,表明质粒介导的喹诺酮类耐药也可单独导致菌株的耐药。存有一个菌株gyrA基因编码的氨基酸发生突变Ser83→Leu,AcrA基因和qnrA、qnrB、qnrS、qepA和aac(6′)-Ib-cr基因检测均为阴性,但是菌株仍然表现为高度耐药,说明还有未知的耐药机制存在。 Quinolone-resistant determining region(QRDR) of gyrA gene,AcrA of Escherichia coli and plasmid-mediated fluoroquinolones resistance gene,qnrA,qnrB,qnrS,qepA and aac(6′)-Ib-cr of 15 clinical isolates of antibiotic-resistant Escherichia coli were detected,sequenced and analyzed by WDNASIS.The results indicated that,the nucleotides were mutated at the sites 72,75,83 and 87 of QRDR.No mutation was detected in the gene of AcrA.The drug resistance gene of qnrS,qepA and aac(6′)-Ib-cr all showed one positive strain,and the sequence analyzsis indicated no amino acids was mutated.There were 4 mutations in the amino acids which coded by QRDR,Ser83→Leu and Asp87→Asn were agreed with the mutations reported by documents.The 7 mutated strains were highly tolerant of fluoroquinolone,indicating gyrA was important for antibiotic-resistant Escherichia coli.The 2 strains in highly tolerant fluoroquinolone strains,were not found with mutation of amino acids.But aac-(6′)-Ib-cr and qnrS were positive which indicated that plasmid-mediated fluoroquinolones resistance gene could lead to resistance along.Ser83→Leu was detected positively in only one amino acid coded by gyrA,and AcrA,qnrA,qnrB,qnrS,qepA and aac(6′)-Ib-cr were negative.But the strain was still highly resistance,which indicated that the mechanism of resistance still uncovered completely.
出处 《中国兽医学报》 CAS CSCD 北大核心 2011年第6期875-879,共5页 Chinese Journal of Veterinary Science
基金 "十一五"国家科技支撑计划资助项目(2008BADB4B04)
关键词 氟喹诺酮类药物 大肠杆菌 突变 耐药性 fluoroquinolones Escherichia coli mutation resistance
  • 相关文献

参考文献23

  • 1陈杖榴.兽医药理学[M].2版.北京:中国农业出版社,2001:234-238.
  • 2Matrat S, Petrella S, Cambau E,et al. Expression and purification of an active form of the Myeobacterium leprae DNA gyrase and its inhibition by quinolones [J]. Antimicrob Agents Chemother, 2007, 51: 1643- 1648.
  • 3Sorlozano A, Gutierrez J, Jimenez A, et al. Contribution of a new mutation in parE to quinolone resistance in extend- ed-spectrum-beta-lactamase-produeing Escherichia coli i solates [J]. J Clin Mierobiol, 2007,45 : 2740-2742.
  • 4Chenia H Y,Pillay B,Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens[J].J Antimicrob Chemother, 2006, 58: 1274-1278.
  • 5Cattoir V, Lesprit P, Lascols C, et al. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid [J].J Antimicrob Chemother, 2006,58 : 1054-1057.
  • 6Nishino K, Yamada J, Hirakawa H, et al. A. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to beta-laetams [J]. Antimicrob Agents Chemother, 2003,47 : 3030-3033.
  • 7Jellen-Ritter A S, Kern W V. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherich- ia coli mutants Selected with a fluoroquinolone[J]. Antimicrob Agents Chemother, 2001,45 : 1467-1472.
  • 8方治平,徐炜,刘小康,宋晓红.大肠杆菌体内氟喹诺酮类药物耐药机制的研究[J].四川大学学报(医学版),2005,36(1):86-89. 被引量:8
  • 9Tran J H, Jacoby G A, Hooper D C. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase[J]. Antimicrob Agents Chemother, 2005,49 : 118-125.
  • 10Wang M,Sahm D F,Jacoby G,et al. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States [J].Antimierob Agents Chemother, 2004,48: 1295-1299.

二级参考文献9

  • 1中华人民共和国卫生部医政司.全国临床检验操作规程(第2版)[M].南京:东南大学出版社,1995.460-462.
  • 2Chapman JS,Georgopapadakou NH. F1uorometric assay for fleroxacin uptake by bacterial cells.Antimicrob. Agents Chemother,1989;33(1):27.
  • 3Mortimer PGS, Piddock LJV.A comparison of methods used for measuring the accumulation of quinolones by Enterob-acteriaceae, Pseudomonas aeruginosa,and Staphylococcusa aureus.J Antimicrob Chemother,1991;28(2):639.
  • 4Nikaido H,Thanassi DG.Penetration of lipophilic agents with multiple protonation sites into bacterial cells:tetracyclines and fluoroquinones as examples. Antimicrob. Agents Chemother,1993;37(7):1393.
  • 5Li XZ, Livermaore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa:Resistance to tetracycline,chloramphenical,and norfloxacin.Antimicrob.Agents Chemother,1994;38(8):1732.
  • 6Mc Murry LM,George AM,Levy SB.Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple- antibiotic- resistant(Mar)mutant. AntimicrobAgents Chemother,1994;38(3):542.
  • 7Thanassi DG,Suh GSB,Nikaido H.Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli.J Bacteriol.1995;177(4):998.
  • 8Mccaffrey C,Bertasso A,Pace J, et al.Quinolone accumulation in Escherichia coli,Pseudomonas aeruginosa,and Staphylococcus. Antimicrob Agents Chemother,1992;36(4):1601.
  • 9Denis A,Moreau NJ.Mechanisms of quinolone resistance in clinic isolates: accumulation of sparfloxacin and fluoroquinolones of various hydrophobicity and analysis of membrane composition.Antimicrob Agents Chemother,1993;32(3):379.

共引文献9

同被引文献117

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部